These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9818787)

  • 1. Antithrombin III, protein C and protein S plasma levels in patients with Behçet's disease.
    Nalçaci M; Pekçelen Y
    J Int Med Res; 1998; 26(4):206-8. PubMed ID: 9818787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial cell activation and hypercoagulability in ocular Behçet's disease.
    Probst K; Fijnheer R; Rothova A
    Am J Ophthalmol; 2004 May; 137(5):850-7. PubMed ID: 15126149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behçet's disease.
    Mader R; Ziv M; Adawi M; Mader R; Lavi I
    J Rheumatol; 1999 Nov; 26(11):2404-8. PubMed ID: 10555901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemostasis in patients with Behçet's disease.
    Demirer S; Sengül N; Yerdel MA; Tüzüner A; Ulus AT; Gürler A; Bergqvist D; Siegbahn A; Karacagil S
    Eur J Vasc Endovasc Surg; 2000 Jun; 19(6):570-4. PubMed ID: 10873722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of desmopressin on protein S and antithrombin III in uremia.
    Akpolat T; Eser M; Albayrak D; Arik N
    Nephron; 1997; 77(3):362. PubMed ID: 9375836
    [No Abstract]   [Full Text] [Related]  

  • 6. Protein S deficiency and antibodies to protein S in patients with Behçet's disease.
    Guermazi S; Hamza M; Dellagi K
    Thromb Res; 1997 May; 86(3):197-204. PubMed ID: 9175241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Natural coagulation inhibitors; antithrombin III, protein C, protein S in children with hypercoagulation due to nephrotic syndrome].
    Wygledowska G; Grygalewicz J; Matuszewska E
    Med Wieku Rozwoj; 2001; 5(4):377-88. PubMed ID: 12004145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein C, protein S, and antithrombin III in twice-frozen plasma.
    Sivakumaran M; Long S; Drury M
    Transfusion; 2005 Feb; 45(2):281. PubMed ID: 15660840
    [No Abstract]   [Full Text] [Related]  

  • 9. Activated protein C levels in Behçet's disease and risk of venous thrombosis.
    Navarro S; Ricart JM; Medina P; Vayá A; Villa P; Todolí J; Estellés A; Micó ML; Aznar J; España F
    Br J Haematol; 2004 Aug; 126(4):550-6. PubMed ID: 15287949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.
    Espinosa G; Font J; Tàssies D; Vidaller A; Deulofeu R; López-Soto A; Cervera R; Ordinas A; Ingelmo M; Reverter JC
    Am J Med; 2002 Jan; 112(1):37-43. PubMed ID: 11812405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of protein C, protein S, and antithrombin III in newborns with sepsis.
    El Beshlawy A; Alaraby I; Abou Hussein H; Abou-Elew HH; Mohamed Abdel Kader MS
    Pediatr Crit Care Med; 2010 Jan; 11(1):52-9. PubMed ID: 19924026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation and fibrinolytic activity in Behçet's disease.
    Hampton KK; Chamberlain MA; Menon DK; Davies JA
    Thromb Haemost; 1991 Sep; 66(3):292-4. PubMed ID: 1745999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antithrombin III, protein C and protein S in children with chronic viral hepatitis B or C].
    Adamska I; Szaflarska-Szczepanik A; Chrobot A; Kulwas A; Czerwionka-Szaflarska M
    Med Wieku Rozwoj; 2003; 7(2):289-97. PubMed ID: 12878800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood coagulation and fibrinolysis in patients with Behçet's disease].
    Fusegawa H; Ichikawa Y; Tanaka Y; Miyachi Y; Kawada T; Gondo K; Ikeda M; Shimizu H; Arimori S; Ando Y
    Rinsho Byori; 1991 May; 39(5):509-16. PubMed ID: 2072574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic parameters of thrombophilia in ocular Behçet disease with posterior segment involvement.
    Citirik M; Haznedaroglu IC; Teberik K; Soykan E; Zilelioglu O
    Br J Ophthalmol; 2009 Oct; 93(10):1382-6. PubMed ID: 19635722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activity of natural coagulation inhibitor proteins in the acute phase of ischaemic stroke].
    Oláh L; Csépány T; Bereczky Z; Kerényi A; Misz M; Kappelmayer J; Csiba L
    Ideggyogy Sz; 2005 Jan; 58(1-2):33-9. PubMed ID: 15884396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural anticoagulant proteins and antiphospholipid antibodies in systemic lupus erythematosus.
    Tomás JF; Alberca I; Tabernero MD; Cordero M; Del Pino-Montes J; Vicente V
    J Rheumatol; 1998 Jan; 25(1):57-62. PubMed ID: 9458203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early drop in protein C and antithrombin III is a predictor for the development of venoocclusive disease in patients undergoing hematopoietic stem cell transplantation.
    Tabbara IA; Ghazal CD; Ghazal HH
    J Hematother; 1996 Feb; 5(1):79-84. PubMed ID: 8646485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of ischemic stroke in young Indians: is thrombophilia profiling a way out?
    Chatterjee T; Gupta N; Choudhry VP; Behari M; Saxena R; Ashraf MZ
    Blood Coagul Fibrinolysis; 2013 Jun; 24(4):449-53. PubMed ID: 23337710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between anti-coagulation system changes of coronary heart disease patients and different syndrome-type in TCM].
    Liang TJ; Gao SZ; Zhang FL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Oct; 15(10):599-600. PubMed ID: 8704425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.